MedPath

Effect of Oxycodone on Anxiety State in Painless Abortion

Early Phase 1
Not yet recruiting
Conditions
Abortion Complication
Interventions
Registration Number
NCT06435949
Lead Sponsor
Ruijin Hospital
Brief Summary

In this study, 300 patients who underwent painless abortion in Ruijin Hospital and sub-central hospitals were selected through a multi-center randomized controlled study, and 300 patients who underwent painless abortion in Ruijin Hospital and each sub-center hospital were divided into intravenous anesthesia with propofol with fentanyl (group F) and propofol with oxycodone (group O) by stratified group randomization method 1:1. The difference between the postoperative anxiety scores and depression scores of the two groups was observed, and the postoperative anxiety, depression and numerical pain scores were recorded. Finally, the relevant data were statistically analyzed and conclusions were drawn.

Detailed Description

This study is a multicenter, randomized controlled clinical study. A total of 300 patients who underwent elective painless abortion surgery in Ruijin Hospital and other sub-central hospitals were enrolled, and they were randomly divided into 1:1 patients who received intravenous anesthesia with propofol with fentanyl (group F) and propofol with oxycodone (group O). The scores of anxiety, depression and postoperative numerical rating scale (NRS) before and after surgery were observed, and the levels of serum stress response factors and inflammatory cytokines were monitored. The effects of oxycodone on anxiety, depression and postoperative acute pain in patients with painless abortion were investigated.

1. Main observation indicators:

The difference between the post-operative anxiety score and the preoperative anxiety score

2. Secondary Observational Indicators:

* Post-operative anxiety score

* The difference between the post-operative depression score and the preoperative depression score

* Post-operative depression score

* Pain assessment after surgical recovery (NRS)

* Laboratory tests

* Patient and family satisfaction with postoperative analgesic treatment

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
300
Inclusion Criteria
  • Age 18-45 years old
  • Gestational age 6-12 weeks
  • American Society of Anesthesiologists (ASA) Grading I-II
  • Fluent communicator and able to complete self-rating scales on her own
  • Voluntarily participate and sign the informed consent form
Exclusion Criteria
  • Patients who are allergic to anesthetic drugs such as propofol, oxycodone, fentanyl, etc., or who have had other anesthetic adverse events
  • Patients with anxiety or depression
  • Presence of organic mental disorders, mental retardation
  • Severe acute and chronic infection, severe heart, liver and kidney insufficiency
  • Patients with complications or bleeding > 50ml during surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
group FentanylFentanyl (as Citrate)intravenous anesthesia with propofol with fentanyl
group OxycodoneFentanyl (as Citrate)intravenous anesthesia with propofol with oxycodone
Primary Outcome Measures
NameTimeMethod
anxiety scores20-30 minutes postoperative

postoperative anxiety scores

Secondary Outcome Measures
NameTimeMethod
depression scores20-30 minutes postoperative

postoperative depression scores

© Copyright 2025. All Rights Reserved by MedPath